Literature DB >> 20621250

The effects of heart failure on renal function.

Suneel M Udani1, Jay L Koyner.   

Abstract

Heart-kidney interactions have been increasingly recognized by clinicians and researchers who study and treat heart failure and kidney disease. A classification system has been developed to categorize the different manifestations of cardiac and renal dysfunction. Work has highlighted the significant negative prognostic effect of worsening renal function on outcomes for individuals with heart failure. The etiology of concomitant cardiac and renal dysfunction remains unclear; however, evidence supports alternatives to the established theory of underfilling, including effects of venous congestion and changes in intra-abdominal pressure. Conventional therapy focuses on blockade of the renin-angiotensin-aldosterone system with expanding use of direct renin and aldosterone antagonists. Novel therapeutic interventions using extracorporeal therapy and antagonists of the adenosine pathway show promise and require further investigation. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20621250      PMCID: PMC2904358          DOI: 10.1016/j.ccl.2010.04.004

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  49 in total

1.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

2.  Intrarenal regulatory factors of salt excretion during renal venous pressure elevation.

Authors:  R L Wathen; E E Selkurt
Journal:  Am J Physiol       Date:  1969-06

3.  Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors.

Authors:  D Sun; L C Samuelson; T Yang; Y Huang; A Paliege; T Saunders; J Briggs; J Schnermann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

4.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

5.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Authors:  G L Bakris; M R Weir
Journal:  Arch Intern Med       Date:  2000-03-13

6.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

Authors:  A Al-Ahmad; W M Rand; G Manjunath; M A Konstam; D N Salem; A S Levey; M J Sarnak
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

7.  Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.

Authors:  Veselin Mitrovic; Petar Seferovic; Slobodan Dodic; Mirjana Krotin; Aleksander Neskovic; Kenneth Dickstein; Hanka de Voogd; Christiane Böcker; Dieter Ziegler; Michael Godes; Roumen Nakov; Hans Essers; Cees Verboom; Berthold Hocher
Journal:  Circ Heart Fail       Date:  2009-09-24       Impact factor: 8.790

8.  Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.

Authors:  John J V McMurray; Bertram Pitt; Roberto Latini; Aldo P Maggioni; Scott D Solomon; Deborah L Keefe; Jessica Ford; Anil Verma; Jim Lewsey
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

9.  Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Authors:  Inder S Anand; Kalkidan Bishu; Thomas S Rector; Areef Ishani; Michael A Kuskowski; Jay N Cohn
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

10.  Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database.

Authors:  Michael Joannidis; Barbara Metnitz; Peter Bauer; Nicola Schusterschitz; Rui Moreno; Wilfred Druml; Philipp G H Metnitz
Journal:  Intensive Care Med       Date:  2009-06-23       Impact factor: 17.440

View more
  13 in total

Review 1.  The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Giorgio Vescovo; Antonio Granata; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-05-14       Impact factor: 2.041

Review 2.  The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.

Authors:  David D McManus; Jane S Saczynski; Jeanine A Ward; Khushleen Jaggi; Peter Bourrell; Chad Darling; Robert J Goldberg
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 3.  Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure.

Authors:  Branko Braam; William A Cupples; Jaap A Joles; Carlo Gaillard
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 4.  Epidemiology and importance of renal dysfunction in heart failure patients.

Authors:  Gregory Giamouzis; Andreas P Kalogeropoulos; Javed Butler; Georgios Karayannis; Vasiliki V Georgiopoulou; John Skoularigis; Filippos Triposkiadis
Journal:  Curr Heart Fail Rep       Date:  2013-12

5.  A Single-Centre Study of Acute Cardiorenal Syndrome: Incidence, Risk Factors and Consequences.

Authors:  Zehra Eren; Olcay Ozveren; Elif Buvukoner; Elif Kaspar; Muzaffer Degertekin; Gulcin Kantarci
Journal:  Cardiorenal Med       Date:  2012-04-27       Impact factor: 2.041

Review 6.  Prevalence and importance of comorbidities in patients with heart failure.

Authors:  Filippos K Triposkiadis; John Skoularigis
Journal:  Curr Heart Fail Rep       Date:  2012-12

7.  Particularities of Older Patients with Obstructive Sleep Apnea and Heart Failure with Mid-Range Ejection Fraction.

Authors:  Carmen Loredana Ardelean; Sorin Pescariu; Daniel Florin Lighezan; Roxana Pleava; Sorin Ursoniu; Valentin Nadasan; Stefan Mihaicuta
Journal:  Medicina (Kaunas)       Date:  2019-08-07       Impact factor: 2.430

8.  Reported Signs, Symptoms, and Diagnostic Tests Before Cardiotoxicity Among Women With Breast Cancer: A Pilot Study.

Authors:  Mina Attin; Karen Reifenstein; Sakshi Mehta; Kimberly Arcoleo; C D Lin; Eugene Storozynsky
Journal:  J Cardiovasc Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.468

9.  Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure.

Authors:  Daniel F Arruda-Junior; Flavia L Martins; Rafael Dariolli; Leonardo Jensen; Ednei L Antonio; Leonardo Dos Santos; Paulo J F Tucci; Adriana C C Girardi
Journal:  Front Physiol       Date:  2016-07-12       Impact factor: 4.566

10.  Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure.

Authors:  Kawa Dizaye; Rojgar H Ali
Journal:  BMC Pharmacol Toxicol       Date:  2019-05-03       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.